表紙:インスリン送達デバイスの世界市場の動向・予測 (2022年~2028年):製品タイプ・流通チャネル・地域別
市場調査レポート
商品コード
1084355

インスリン送達デバイスの世界市場の動向・予測 (2022年~2028年):製品タイプ・流通チャネル・地域別

Insulin Delivery Devices Market, by Product Type, Distribution Channel, and Geography - Global Trends, and Forecast, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 150 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
インスリン送達デバイスの世界市場の動向・予測 (2022年~2028年):製品タイプ・流通チャネル・地域別
出版日: 2022年05月27日
発行: Coherent Market Insights
ページ情報: 英文 150 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

インスリン送達デバイスの市場は、糖尿病患者の増加や設計面での新たな技術革新により、大きな牽引力を得ています。WHOによると、2021年には、世界で推定4億2,200万人の成人が糖尿病に罹患しています。過去10年間における2型糖尿病の発症率の大きな急増は、主に肥満の拡大に起因しています。一方で、一部のインスリン送達デバイスが高コストであり、市場成長の抑制要因になると予想されています。

当レポートでは、世界のインスリン送達デバイスの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、技術動向、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提因子

第2章 市場概要

第3章 市場力学・法規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 技術の進歩
  • 規制シナリオ
  • 産業動向
  • PEST分析
  • ポーターの分析

第4章 世界のインスリン送達デバイス市場:製品タイプ別

  • インスリン注射器
  • インスリンポンプ
  • インスリンペン
  • インスリンジェットインジェクター

第5章 世界のインスリン送達デバイス市場:流通チャネル別

  • 院内薬局
  • 小売薬局
  • オンライン薬局

第6章 世界のインスリン送達デバイス市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • アフリカ
  • 中東

第7章 競合情勢

  • ヒートマップ分析
  • 市場シェア分析
  • 企業プロファイル
    • Novo Nordisk A/S
    • Becton, Dickinson and Company
    • Sanofi SA
    • F. Hoffmann-La Roche, Ltd.
    • Eli Lilly and Company
    • Medtronic, Plc
    • Ypsomed Holding AG
    • Animas Corporation
    • Insulet Corporation
  • アナリストの見解

第8章 セクション

目次
Product Code: CMI1352

Direct subcutaneous insulin injection are the most common form of drug delivery, using a needle and syringe. There are different types of insulin delivery devices available including, syringes, pens, jet injectors, and insulin pumps. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. However, several disposable and reusable pen devices have been developed that provide options for delivering rapid insulins and insulin premixes. Type or dosage of insulin can be changed according to the requirements to meet the individual needs of the patient Manufacturers are focusing on designing products, which are cost effective for people with diabetes which is expected to propel the growth of the insulin delivery devices market. For instance, in July 2017, Becton, Dickinson and Company launched BD Viva pen needles, have a highly engineered needle tip design for improved comfort and considered as the most cost-effective option for insulin-injecting people with diabetes in the UK.

Market Dynamics

The market is gaining significant traction due to increasing prevalence of diabetes, and new innovations in terms of design. According to the World Health Organization, in 2021, an estimated 422 million adults are living with diabetes globally. The major spike in incidence of type 2 diabetes over the last decade is mainly attributed to rising prevalence of obesity. However, high cost of some insulin delivery devices is expected to be a restraining factor for the market growth. For instance, insulin analogs supplied in cartridges or prefilled pens have a higher per unit of insulin cost than insulin analogs supplied in vials. For example, one vial (1000 U) of insulin costs US$ 105.95, which equates to a cost of 10.6 cents per unit of insulin. Five prefilled insulin pens containing insulin glulisine (total of 1500 U) have a total cost of US$ 201.01, equating to a cost of 13.4 cents per unit of insulin (26% over the cost of insulin glulisine supplied in a vial).

Key features of the study:

This report provides in-depth analysis of the insulin delivery devices market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global insulin delivery devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans

Key companies covered as a part of this study include Novo Nordisk A/S, Becton, Dickinson and Company, Sanofi S.A.., F. Hoffmann-La Roche, Ltd., Eli Lilly and Company, Medtronic, Plc, Ypsomed Holding AG, Animas Corporation, and Insulet Corporation.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics.

The global insulin delivery devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of insulin delivery devices, research and consulting firms, new entrants, and financial analysts

Various strategy matrices used in analyzing the insulin delivery devices market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Insulin Delivery Devices Market, By Product Type:

Insulin Syringes

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

Global Insulin Delivery Devices Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Insulin Delivery Devices Market, By Geography:

North America

By Country:

U.S.

Canada

By Product Type:

Insulin Syringes

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Europe

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

By Product Type:

Insulin Syringes

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Asia Pacific

By Country:

China

India

Japan

ASEAN

Australia

South Korea

By Product Type:

Insulin Syringes

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

By Product Type:

Insulin Syringes

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Middle East

By Country:

GCC

Israel

Rest of Middle East

By Product Type:

Insulin Syringes

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Africa

By Country:

North Africa

Central Africa

South Africa

By Product Type:

Insulin Syringes

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Company Profiles

Novo Nordisk A/S*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Future Plans

Becton, Dickinson and Company

Sanofi S.A.

F. Hoffmann-La Roche, Ltd.

Eli Lilly and Company

Medtronic, Plc

Ypsomed Holding AG

Animas Corporation

Insulet Corporation

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Industry Trends
  • PEST Analysis
  • PORTER'S Five Forces

4. Global Insulin Delivery Devices Market, By Product Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Insulin Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Insulin Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Insulin Pens
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Insulin Jet Injectors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Insulin Delivery Devices Market, By Distribution Channel, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Insulin Delivery Devices Market, By Region, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2028
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Novo Nordisk A/S
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Becton, Dickinson and Company
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Sanofi S.A.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • F. Hoffmann-La Roche, Ltd.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Eli Lilly and Company
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Medtronic, Plc
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Ypsomed Holding AG
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Animas Corporation
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Insulet Corporation
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact